Manifest Investing

Company	Ticker	Sector \| Industry	Quality	PAR
Jazz Pharmaceuticals	JAZZ	Healthcare \| Biotechnology	95	19.2%

Current Price (02/27)			$113.10
CAPS Rating (Rate this stock on CAPS)

Expected Income Statement
Current Sales			2,056.5
Sales Growth Forecast			11.5%
Net Profit Margin			47.6%

Projected Shares Outstanding			61.99
EPS - Five year Forecast			$27.25
Average P/E Ratio			10.0
Projected Average Price			$272.52

Price Appreciation (Annualized)			19.2%
Annual Dividend Yield			0.0%
Projected Annual Return			19.2%

Quality
Financial Strength			95	23.7
EPS Stability			95	23.8
Industry Sales Growth Rate			16.5%	8.7
Industry Net Profit Margin			29.0%	20.5
Calculated Quality Rating			76.7

Fool CAPS
Total Players 289 Outperforms 67 Underperforms All-Stars (53) 40 Outperforms (75%) 13 Underperforms

Fundamental Data Updated: 01/31/2020

MIPAR	10.8%
Sweet Spot	15.8% - 20.8%

Quality Legend:
Blue	Excellent with quality greater than 80.
Green	Good with quality between 60 and 80.
Neutral	Average or below average with quality between 20 and 60.
Red	Poor with quality less than 20.
Companies with less than 10 years of history are penalized by 5 points per year.
PAR Legend:
Green	PAR is within the target range of MIPAR +5-10%, currently 15.8%-20.8%
Yellow	PAR is above the target range of MIPAR +10%, currently 20.8%
PAR	Projected Annual Return
MIPAR	The Manifest Investing Median PAR of all stocks in the database.
Company Name Legend:
*	Not covered by Value Line Standard Edition.
b	Uses price-to-book value for valuation purposes.
P/CF	Uses price-to-cash flow for valuation.